Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10857)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2014 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lytras T, Nikolopoulos G, Bonovas S. Statins and the risk of colorectal cancer: An updated systematic review and meta-analysis of 40 studies. World J Gastroenterol 2014; 20(7): 1858-1870 [PMID: 24587664 DOI: 10.3748/wjg.v20.i7.1858] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i7/1858.htm |
| Number | Citing Articles |
| 1 |
Ka Shing Cheung. Big data approach in the field of gastric and colorectal cancer research. Journal of Gastroenterology and Hepatology 2024; 39(6): 1027 doi: 10.1111/jgh.16527
|
| 2 |
E. Rodríguez de Santiago, B. Peñas, F. Mesonero, S. Parejo, A. Albillos. Cáncer colorrectal. Medicine - Programa de Formación Médica Continuada Acreditado 2016; 12(6): 297 doi: 10.1016/j.med.2016.03.003
|
| 3 |
Simona Pisanti, Paola Picardi, Elena Ciaglia, Alba D’Alessandro, Maurizio Bifulco. Novel prospects of statins as therapeutic agents in cancer. Pharmacological Research 2014; 88: 84 doi: 10.1016/j.phrs.2014.06.013
|
| 4 |
Prashanth Francis, Lisa M. Forman. Statins Show Promise Against Progression of Liver Disease. Clinical Liver Disease 2021; 18(6): 280 doi: 10.1002/cld.1143
|
| 5 |
Sami Erkinantti, Mikko Marttila, Reijo Sund, Martti Arffman, Elina Urpilainen, Ulla Puistola, Ari Hautakoski, Peeter Karihtala, Esa Läärä, Arja Jukkola. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes. Clinical Colorectal Cancer 2021; 20(2): e113 doi: 10.1016/j.clcc.2020.11.003
|
| 6 |
Minos Kritikos, Sean A. P. Clouston. Hybrid PET/MR Neuroimaging. 2022; : 35 doi: 10.1007/978-3-030-82367-2_5
|
| 7 |
Jonathan T. Davies, Spencer F. Delfino, Chad E. Feinberg, Meghan F. Johnson, Veronica L. Nappi, Joshua T. Olinger, Anthony P. Schwab, Hollie I. Swanson. Current and Emerging Uses of Statins in Clinical Therapeutics: A Review. Lipid Insights 2016; 9 doi: 10.4137/LPI.S37450
|
| 8 |
David Bergman, Hamed Khalili, Bjorn Roelstraete, Jonas F Ludvigsson. Microscopic Colitis and Risk Of Cancer—AA Population-Based Cohort Study. Journal of Crohn's and Colitis 2021; 15(2): 212 doi: 10.1093/ecco-jcc/jjaa156
|
| 9 |
Masao Iwagami, Atsushi Goto, Ryoko Katagiri, Yoichi Sutoh, Yuriko N. Koyanagi, Masahiro Nakatochi, Shiori Nakano, Akiko Hanyuda, Akira Narita, Atsushi Shimizu, Kozo Tanno, Atsushi Hozawa, Kengo Kinoshita, Isao Oze, Hidemi Ito, Taiki Yamaji, Norie Sawada, Yohko Nakamura, Sho Nakamura, Kiyonori Kuriki, Sadao Suzuki, Asahi Hishida, Yumiko Kasugai, Issei Imoto, Midori Suzuki, Yukihide Momozawa, Kenji Takeuchi, Masayuki Yamamoto, Makoto Sasaki, Keitaro Matsuo, Shoichiro Tsugane, Kenji Wakai, Motoki Iwasaki. Blood Lipids and the Risk of Colorectal Cancer: Mendelian Randomization Analyses in the Japanese Consortium of Genetic Epidemiology Studies. Cancer Prevention Research 2022; 15(12): 827 doi: 10.1158/1940-6207.CAPR-22-0146
|
| 10 |
Carmen Jochem, Michael Leitzmann. Prävention gastroenterologischer Tumorerkrankungen. 2020; : 87 doi: 10.1007/978-3-662-58879-6_5
|
| 11 |
Brian Rutledge, Pinkal Desai, Simin Liu, Juhua Luo, Rami Nassir, Qi Lihong, Monica Arun, Mahmoud Abdel‑Rasoul, Michael Simon. The association between statins and colorectal cancer stage in the Women's Health Initiative. Molecular and Clinical Oncology 2019; doi: 10.3892/mco.2019.1895
|
| 12 |
Chen Zhang, Yunjiu Cheng, Dongling Luo, Jinghua Wang, Jianhua Liu, Yujun Luo, Weijie Zhou, Zewei Zhuo, Kehang Guo, Ruijie Zeng, Jun Yang, Weihong Sha, Hao Chen. Association between cardiovascular risk factors and colorectal cancer: A systematic review and meta-analysis of prospective cohort studies. EClinicalMedicine 2021; 34: 100794 doi: 10.1016/j.eclinm.2021.100794
|
| 13 |
Ashwin N. Ananthakrishnan, Andrew Cagan, Tianxi Cai, Vivian S. Gainer, Stanley Y. Shaw, Susanne Churchill, Elizabeth W. Karlson, Shawn N. Murphy, Katherine P. Liao, Isaac Kohane. Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2016; 14(7): 973 doi: 10.1016/j.cgh.2016.02.017
|
| 14 |
Gemma Ibáñez-Sanz, Anna Díez-Villanueva, Marina Riera-Ponsati, Tania Fernández-Villa, Pablo Fernández Navarro, Mariona Bustamante, Javier Llorca, Pilar Amiano, Nieves Ascunce, Guillermo Fernández-Tardón, Inmaculada Salcedo Bellido, Dolores Salas, Rocío Capelo Álvarez, Marta Crous-Bou, Luis Ortega-Valín, Beatriz Pérez-Gómez, Gemma Castaño-Vinyals, Camilo Palazuelos, Jone M. Altzibar, Eva Ardanaz, Adonina Tardón, José Juan Jiménez Moleón, Valle Olmos Juste, Nuria Aragonés, Marina Pollán, Manolis Kogevinas, Victor Moreno. Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49880-w
|
| 15 |
Ka Shing Cheung, Esther W. Chan, Anthony Tam, Irene O. L. Wong, Wai Kay Seto, Ivan F. N. Hung, Ian C. K. Wong, Wai K. Leung. Association between antibiotic consumption and colon and rectal cancer development in older individuals: A territory‐wide study. Cancer Medicine 2022; 11(20): 3863 doi: 10.1002/cam4.4759
|
| 16 |
Guo-Chao Zhong, Yan Liu, Yuan-Yuan Ye, Fa-Bao Hao, Kang Wang, Jian-Ping Gong. Meta-analysis of studies using statins as a reducer for primary liver cancer risk. Scientific Reports 2016; 6(1) doi: 10.1038/srep26256
|
| 17 |
Xin Hong, Whijae Roh, Ryan J. Sullivan, Keith H.K. Wong, Ben S. Wittner, Hongshan Guo, Taronish D. Dubash, Moshe Sade-Feldman, Benjamin Wesley, Elad Horwitz, Genevieve M. Boland, Dieuwke L. Marvin, Todd Bonesteel, Chenyue Lu, François Aguet, Risa Burr, Samuel S. Freeman, Laxmi Parida, Katherine Calhoun, Michelle K. Jewett, Linda T. Nieman, Nir Hacohen, Anders M. Näär, David T. Ting, Mehmet Toner, Shannon L. Stott, Gad Getz, Shyamala Maheswaran, Daniel A. Haber. The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis. Cancer Discovery 2021; 11(3): 678 doi: 10.1158/2159-8290.CD-19-1500
|
| 18 |
Neil Murphy, Victor Moreno, David J. Hughes, Ludmila Vodicka, Pavel Vodicka, Elom K. Aglago, Marc J. Gunter, Mazda Jenab. Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Molecular Aspects of Medicine 2019; 69: 2 doi: 10.1016/j.mam.2019.06.005
|
| 19 |
Rhea Harewood, Ruth Disney, James Kinross, Christian von Wagner, Amanda J. Cross. Medication use and risk of proximal colon cancer: a systematic review of prospective studies with narrative synthesis and meta-analysis. Cancer Causes & Control 2021; 32(10): 1047 doi: 10.1007/s10552-021-01472-8
|
| 20 |
Yuanbin Liu, Mingkai Chen. Insights into the underlying mechanisms and clinical management of microscopic colitis in relation to other gastrointestinal disorders. Gastroenterology Report 2022; 10 doi: 10.1093/gastro/goac011
|
| 21 |
Peter Kubatka, Peter Kruzliak, Vladimir Rotrekl, Sarka Jelinkova, Beata Mladosievicova. Statins in oncological research: From experimental studies to clinical practice. Critical Reviews in Oncology/Hematology 2014; 92(3): 296 doi: 10.1016/j.critrevonc.2014.08.002
|
| 22 |
Mo Zhou, Jinkai Zheng, Jinfeng Bi, Xinye Wu, Jian Lyu, Kun Gao. Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin. Oncology Letters 2017; doi: 10.3892/ol.2017.7480
|
| 23 |
Elizabeth G. Ratcliffe, Mohamed Shibeika, Andrew D. Higham, Janusz A. Jankowski. Esophageal Cancer. 2020; : 113 doi: 10.1007/978-3-030-29832-6_5
|
| 24 |
Taskeen Fathima Docrat, Savania Nagiah, Anand Krishnan, Dhaneshree B. Naidoo, Anil A. Chuturgoon. Atorvastatin induces MicroRNA-145 expression in HEPG2 cells via regulation of the PI3K/AKT signalling pathway. Chemico-Biological Interactions 2018; 287: 32 doi: 10.1016/j.cbi.2018.04.005
|
| 25 |
Linda Sleire, Hilde Elise Førde, Inger Anne Netland, Lina Leiss, Bente Sandvei Skeie, Per Øyvind Enger. Drug repurposing in cancer. Pharmacological Research 2017; 124: 74 doi: 10.1016/j.phrs.2017.07.013
|
| 26 |
Nicolas Chapelle, Myriam Martel, Esther Toes-Zoutendijk, Alan N Barkun, Marc Bardou. Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population. Gut 2020; 69(12): 2244 doi: 10.1136/gutjnl-2020-320990
|
| 27 |
Yong Zhang, Weijia Kong, Jiandong Jiang. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms. Science China Life Sciences 2017; 60(6): 601 doi: 10.1007/s11427-017-9047-4
|
| 28 |
Caroline J. Bull, Joshua A. Bell, Neil Murphy, Eleanor Sanderson, George Davey Smith, Nicholas J. Timpson, Barbara L. Banbury, Demetrius Albanes, Sonja I. Berndt, Stéphane Bézieau, D. Timothy Bishop, Hermann Brenner, Daniel D. Buchanan, Andrea Burnett-Hartman, Graham Casey, Sergi Castellví-Bel, Andrew T. Chan, Jenny Chang-Claude, Amanda J. Cross, Albert de la Chapelle, Jane C. Figueiredo, Steven J. Gallinger, Susan M. Gapstur, Graham G. Giles, Stephen B. Gruber, Andrea Gsur, Jochen Hampe, Heather Hampel, Tabitha A. Harrison, Michael Hoffmeister, Li Hsu, Wen-Yi Huang, Jeroen R. Huyghe, Mark A. Jenkins, Corinne E. Joshu, Temitope O. Keku, Tilman Kühn, Sun-Seog Kweon, Loic Le Marchand, Christopher I. Li, Li Li, Annika Lindblom, Vicente Martín, Anne M. May, Roger L. Milne, Victor Moreno, Polly A. Newcomb, Kenneth Offit, Shuji Ogino, Amanda I. Phipps, Elizabeth A. Platz, John D. Potter, Conghui Qu, J. Ramón Quirós, Gad Rennert, Elio Riboli, Lori C. Sakoda, Clemens Schafmayer, Robert E. Schoen, Martha L. Slattery, Catherine M. Tangen, Kostas K. Tsilidis, Cornelia M. Ulrich, Fränzel J. B. van Duijnhoven, Bethany van Guelpen, Kala Visvanathan, Pavel Vodicka, Ludmila Vodickova, Hansong Wang, Emily White, Alicja Wolk, Michael O. Woods, Anna H. Wu, Peter T. Campbell, Wei Zheng, Ulrike Peters, Emma E. Vincent, Marc J. Gunter. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study. BMC Medicine 2020; 18(1) doi: 10.1186/s12916-020-01855-9
|
| 29 |
Xiao Bo Yang, Qing Ling Xu, Chen Ying Xu, Chao Wu, Li Fen Yu. Prevalence of colorectal neoplasm in Chinese patients with high‐risk coronary artery disease classified by the Asia–Pacific Colorectal Screening score. Journal of Digestive Diseases 2015; 16(5): 272 doi: 10.1111/1751-2980.12243
|
| 30 |
Kyle J. Gu, Guojun Li. An Overview of Cancer Prevention: Chemoprevention and Immunoprevention. Journal of Cancer Prevention 2020; 25(3): 127 doi: 10.15430/JCP.2020.25.3.127
|
| 31 |
Gwang Hun Jeong, Keum Hwa Lee, Jong Yeob Kim, Michael Eisenhut, Andreas Kronbichler, Hans J. van der Vliet, Sung Hwi Hong, Jae Il Shin, Gabriele Gamerith. Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2019; 8(6): 819 doi: 10.3390/jcm8060819
|
| 32 |
Cheng Han Ng, Margaret LP Teng, Nicholas WS Chew, Kai En Chan, Jie Ning Yong, Jingxuan Quek, Darren Jun Hao Tan, Wen Hui Lim, Gabriel Sheng Jie Lee, Jessica Wong, Apichat Kaewdech, Daniel Q Huang, Jiongwei Wang, Mark Y Chan, Mazen Noureddin, Mohammad Shadab Siddiqui, Arun Sanyal, Mark Muthiah. Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals. Expert Review of Gastroenterology & Hepatology 2022; 16(9): 895 doi: 10.1080/17474124.2022.2119128
|
| 33 |
Daniel Teschner, Mirjeta Berisha, Jens Panse, Timo Schmitt, Eva Fiegle, Jan‐Hendrik Naendrup, Julia Neitz, Martin Schmidt‐Hieber, Marcus Hentrich, Boris Böll, Enrico Schalk. Chlorhexidine gluconate‐coated gel pad dressings for prevention of central venous catheter‐related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry‐based matched‐pair analysis. European Journal of Haematology 2023; 111(6): 914 doi: 10.1111/ejh.14098
|
| 34 |
Gemma Ibáñez-Sanz, Elisabet Guinó, Caridad Pontes, Mª Ángeles Quijada-Manuitt, Luisa C de la Peña-Negro, María Aragón, Marga Domínguez, Lorena Rodríguez-Alonso, Alex Blasco, Ana García-Rodríguez, Rosa Morros, Victor Moreno. Statin use and the risk of colorectal cancer in a population-based electronic health records study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49877-5
|
| 35 |
Nourah Alsheridah, Saeed Akhtar. Diet, obesity and colorectal carcinoma risk: results from a national cancer registry-based middle-eastern study. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-5132-9
|
| 36 |
Nalinie Joharatnam-Hogan, Leo Alexandre, James Yarmolinsky, Blossom Lake, Nigel Capps, Richard M Martin, Alistair Ring, Fay Cafferty, Ruth E Langley. Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs. Current Oncology Reports 2021; 23(3) doi: 10.1007/s11912-021-01023-z
|
| 37 |
Krishna Undela, Chirag S Shah, Raj K Mothe. Statin use and risk of cancer: An overview of meta-analyses. World Journal of Meta-Analysis 2017; 5(2): 41-53 doi: 10.13105/wjma.v5.i2.41
|
| 38 |
Antonio Rodríguez-Miguel, Encarnación Fernández-Antón, Diana Barreira-Hernández, Luis A. García-Rodríguez, Miguel Gil, Alberto García-Lledó, Francisco J. De Abajo. Statins and Colorectal Cancer Risk: A Population-Based Case-Control Study and Synthesis of the Epidemiological Evidence. Journal of Clinical Medicine 2022; 11(6): 1528 doi: 10.3390/jcm11061528
|
| 39 |
Geoffrey C. Kabat, Mimi Y. Kim, Rowan T. Chlebowski, Mara Z. Vitolins, Sylvia Wassertheil-Smoller, Thomas E. Rohan. Serum lipids and risk of obesity-related cancers in postmenopausal women. Cancer Causes & Control 2018; 29(1): 13 doi: 10.1007/s10552-017-0991-y
|
| 40 |
Valentina Rosato, Alessandra Tavani, Esther Gracia-Lavedan, Elisabet Guinó, Gemma Castaño-Vinyals, Cristina M. Villanueva, Manolis Kogevinas, Jerry Polesel, Diego Serraino, Federica E. Pisa, Fabio Barbone, Victor Moreno, Carlo La Vecchia, Cristina Bosetti. Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case–Control Studies from Italy and Spain. Frontiers in Oncology 2016; 6 doi: 10.3389/fonc.2016.00210
|
| 41 |
Ruby Kasana, Christy Thomas, Gaurav Das, Munlima Hazarika, Krishna Undela. Statin use and risk of cancer. Annals of Oncology Research and Therapy 2023; 3(1): 14 doi: 10.4103/aort.aort_34_22
|
| 42 |
Henry Rodriguez‐Broadbent, Philip J. Law, Amit Sud, Kimmo Palin, Sari Tuupanen, Alexandra Gylfe, Ulrika A. Hänninen, Tatiana Cajuso, Tomas Tanskanen, Johanna Kondelin, Eevi Kaasinen, Antti‐Pekka Sarin, Samuli Ripatti, Johan G. Eriksson, Harri Rissanen, Paul Knekt, Eero Pukkala, Pekka Jousilahti, Veikko Salomaa, Aarno Palotie, Laura Renkonen‐Sinisalo, Anna Lepistö, Jan Böhm, Jukka‐Pekka Mecklin, Nada A. Al‐Tassan, Claire Palles, Lynn Martin, Ella Barclay, Susan M. Farrington, Maria N. Timofeeva, Brian F. Meyer, Salma M. Wakil, Harry Campbell, Christopher G. Smith, Shelley Idziaszczyk, Timothy S. Maughan, Richard Kaplan, Rachel Kerr, David Kerr, Michael N. Passarelli, Jane C. Figueiredo, Daniel D. Buchanan, Aung K. Win, John L. Hopper, Mark A. Jenkins, Noralane M. Lindor, Polly A. Newcomb, Steven Gallinger, David Conti, Fred Schumacher, Graham Casey, Lauri A. Aaltonen, Jeremy P. Cheadle, Ian P. Tomlinson, Malcolm G. Dunlop, Richard S. Houlston. Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer. International Journal of Cancer 2017; 140(12): 2701 doi: 10.1002/ijc.30709
|
| 43 |
Qi-Jun Wu, Chao Tu, Yuan-Yuan Li, Jingjing Zhu, Ke-Qing Qian, Wen-Jing Li, Lang Wu. Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget 2015; 6(40): 42988 doi: 10.18632/oncotarget.5557
|
| 44 |
Yin Zhang, Kana Wu, Andrew T. Chan, Jeffrey A. Meyerhardt, Edward L. Giovannucci. Long-Term Statin Use, Total Cholesterol Level, and Risk of Colorectal Cancer: A Prospective Cohort Study. American Journal of Gastroenterology 2021; doi: 10.14309/ajg.0000000000001543
|
| 45 |
Michael J Hall. Updates in Chemoprevention Research for Hereditary Gastrointestinal and Polyposis Syndromes. Current Treatment Options in Gastroenterology 2021; 19(1): 30 doi: 10.1007/s11938-020-00306-x
|
| 46 |
Dandi Lou, Rongrong Fu, Lihu Gu, Hui Su, like Guan. Association between statins’ exposure with incidence and prognosis of gastric cancer: an updated meta‐analysis. Expert Review of Clinical Pharmacology 2022; 15(9): 1127 doi: 10.1080/17512433.2022.2112178
|
| 47 |
Timothy L. Lash, Anders H. Riis, Eva B. Ostenfeld, Rune Erichsen, Mogens Vyberg, Thomas P. Ahern, Ole Thorlacius-Ussing. Associations of Statin Use With Colorectal Cancer Recurrence and Mortality in a Danish Cohort. American Journal of Epidemiology 2017; 186(6): 679 doi: 10.1093/aje/kww245
|
| 48 |
James Sinnett-Smith, M. Eugenia Torres-Marquez, Jen-Kuan Chang, Yuki Shimizu, Fang Hao, Martin G. Martin, Enrique Rozengurt. Statins inhibit protein kinase D (PKD) activation in intestinal cells and prevent PKD1-induced growth of murine enteroids. American Journal of Physiology-Cell Physiology 2023; 324(4): C807 doi: 10.1152/ajpcell.00286.2022
|
| 49 |
Ka Shing Cheung, Lijia Chen, Esther W. Chan, Wai Kay Seto, Ian C.K. Wong, Wai K. Leung. Nonsteroidal anti‐inflammatory drugs but not aspirin are associated with a lower risk of post‐colonoscopy colorectal cancer. Alimentary Pharmacology & Therapeutics 2020; 51(9): 899 doi: 10.1111/apt.15693
|
| 50 |
Stefanos Bonovas. Statins: Do They Have a Potential Role in Cancer Prevention and Modifying Cancer-Related Outcomes?. Drugs 2014; 74(16): 1841 doi: 10.1007/s40265-014-0309-2
|
| 51 |
Kyu-Tae Han, Seungju Kim, Antonio Palazón-Bru. Do cholesterol levels and continuity of statin use affect colorectal cancer incidence in older adults under 75 years of age?. PLOS ONE 2021; 16(4): e0250716 doi: 10.1371/journal.pone.0250716
|
| 52 |
Vassiliki Benetou, Areti Lagiou, Pagona Lagiou. Chemoprevention of cancer: current evidence and future prospects. F1000Research 2015; 4: 916 doi: 10.12688/f1000research.6684.1
|
| 53 |
Simer J. Bains, Milada Mahic, Tor Åge Myklebust, Milada Cvancarova Småstuen, Sheraz Yaqub, Liv Marit Dørum, Bjørn Atle Bjørnbeth, Bjørn Møller, Kristoffer Watten Brudvik, Kjetil Taskén. Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study. Journal of Clinical Oncology 2016; 34(21): 2501 doi: 10.1200/JCO.2015.65.3519
|
| 54 |
Ferran Moratalla-Navarro, Robert Carreras-Torres, Virginia Díez-Obrero, Matthew Devall, Mireia Obón-Santacana, Anna Díez-Villanueva, Elisabet Guinó, Graham Casey, Li Li, Victor Moreno. Exploring the Chemopreventive Effect of Medication on Gene Expression Linked to Colorectal Cancer: An Observational and Mendelian Randomization Analysis in Healthy Colon Mucosa. International Journal of Molecular Sciences 2024; 25(21): 11395 doi: 10.3390/ijms252111395
|
| 55 |
Gemma Ibáñez-Sanz, Anna Díez-Villanueva, M. Henar Alonso, Francisco Rodríguez-Moranta, Beatriz Pérez-Gómez, Mariona Bustamante, Vicente Martin, Javier Llorca, Pilar Amiano, Eva Ardanaz, Adonina Tardón, Jose J. Jiménez-Moleón, Rosana Peiró, Juan Alguacil, Carmen Navarro, Elisabet Guinó, Gemma Binefa, Pablo Fernández-Navarro, Anna Espinosa, Verónica Dávila-Batista, Antonio José Molina, Camilo Palazuelos, Gemma Castaño-Vinyals, Nuria Aragonés, Manolis Kogevinas, Marina Pollán, Victor Moreno. Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study. Scientific Reports 2017; 7(1) doi: 10.1038/srep43263
|
| 56 |
Yoon Suk Jung, Chan Hyuk Park, Chang Soo Eun, Dong Il Park, Dong Soo Han. Statin use and the risk of colorectal adenoma: A meta‐analysis. Journal of Gastroenterology and Hepatology 2016; 31(11): 1823 doi: 10.1111/jgh.13393
|
| 57 |
Changlong Yang, Zhenglin Chang, Youguo Dai, Jinzhao Mo, Qitai Zhang, Mingming Zhu, Likun Luan, Jinhu Zhang, Baoqing Sun, Junyi Jia, Yazhou He. Trans-ancestry analysis in over 799,000 individuals yields new insights into the genetic etiology of colorectal cancer. PLOS ONE 2024; 19(7): e0301811 doi: 10.1371/journal.pone.0301811
|
| 58 |
Baoge Qu, Hao Qu. The Influence of Statins on Risk and Patient Survival in Colorectal Cancer. Journal of Clinical Gastroenterology 2019; 53(9): 699 doi: 10.1097/MCG.0000000000000844
|
| 59 |
Zsuzsanna Schelz, Hiba F. Muddather, István Zupkó. Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance. Antibiotics 2023; 12(9): 1468 doi: 10.3390/antibiotics12091468
|
| 60 |
Søren Friis, Ausrele Kesminiene, Carolina Espina, Anssi Auvinen, Kurt Straif, Joachim Schüz. European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer. Cancer Epidemiology 2015; 39: S107 doi: 10.1016/j.canep.2015.08.003
|
| 61 |
Stefanos Bonovas, Gionata Fiorino, Theodore Lytras, Alberto Malesci, Silvio Danese. Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials. World Journal of Gastroenterology 2016; 22(18): 4594-4603 doi: 10.3748/wjg.v22.i18.4594
|
| 62 |
Riccardo Giampieri, Luca Cantini, Enrica Giglio, Alessandro Bittoni, Andrea Lanese, Sonia Crocetti, Federica Pecci, Cecilia Copparoni, Tania Meletani, Edoardo Lenci, Alessio Lupi, Maria Giuditta Baleani, Rossana Berardi. Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing. Cancers 2020; 12(10): 2724 doi: 10.3390/cancers12102724
|
| 63 |
Paulina Rzasa, Sarah Whelan, Pooyeh Farahmand, Hong Cai, Inna Guterman, Raquel Palacios-Gallego, Shanthi S. Undru, Lauren Sandford, Caleb Green, Catherine Andreadi, Maria Mintseva, Emma Parrott, Hong Jin, Fiona Hey, Susan Giblett, Nicolas B. Sylvius, Natalie S. Allcock, Anna Straatman-Iwanowska, Roberto Feuda, Cristina Tufarelli, Karen Brown, Catrin Pritchard, Alessandro Rufini. BRAFV600E-mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism. Communications Biology 2023; 6(1) doi: 10.1038/s42003-023-05331-x
|
| 64 |
Sneha Tripathi, Ekta Gupta, Sanjeev Galande. Statins as anti‐tumor agents: A paradigm for repurposed drugs. Cancer Reports 2024; 7(5) doi: 10.1002/cnr2.2078
|
| 65 |
David Renman, Erik Lundberg, Ulf Gunnarsson, Karin Strigård. Statin consumption as a risk factor for developing colorectal cancer: a retrospective case study. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1287-0
|
| 66 |
P.R. Carr, E. Alwers, S. Bienert, J. Weberpals, M. Kloor, H. Brenner, M. Hoffmeister. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses. Annals of Oncology 2018; 29(4): 825 doi: 10.1093/annonc/mdy059
|
| 67 |
Peter S. Liang, Aasma Shaukat, Seth D. Crockett. AGA Clinical Practice Update on Chemoprevention for Colorectal Neoplasia: Expert Review. Clinical Gastroenterology and Hepatology 2021; 19(7): 1327 doi: 10.1016/j.cgh.2021.02.014
|
| 68 |
Jiangwei Sun, Jonas Halfvarson, David Bergman, Fahim Ebrahimi, Bjorn Roelstraete, Paul Lochhead, Mingyang Song, Ola Olén, Jonas F. Ludvigsson. Statin use and risk of colorectal cancer in patients with inflammatory bowel disease. eClinicalMedicine 2023; 63: 102182 doi: 10.1016/j.eclinm.2023.102182
|
| 69 |
Beniamin Oskar Grabarek, Dariusz Boroń, Emilia Morawiec, Piotr Michalski, Veronica Palazzo-Michalska, Łukasz Pach, Barbara Dziuk, Magdalena Świder, Nikola Zmarzły. Crosstalk between Statins and Cancer Prevention and Therapy: An Update. Pharmaceuticals 2021; 14(12): 1220 doi: 10.3390/ph14121220
|
| 70 |
ABDULLAH K. ALTWAIRGI. Statins are potential anticancerous agents (Review). Oncology Reports 2015; 33(3): 1019 doi: 10.3892/or.2015.3741
|
| 71 |
Cristina Bezzio, Stefano Festa, Simone Saibeni, Claudio Papi. Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence. Expert Review of Gastroenterology & Hepatology 2017; 11(4): 339 doi: 10.1080/17474124.2017.1292129
|
| 72 |
Michael T Marrone, Alison M Mondul, Anna E Prizment, David Couper, John R Barber, Meera R Chappidi, Corinne E Joshu, Elizabeth A Platz. Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study. JNCI Cancer Spectrum 2021; 5(5) doi: 10.1093/jncics/pkab080
|
| 73 |
Alex J. Cornish, Ian P.M. Tomlinson, Richard S. Houlston. Mendelian randomisation: A powerful and inexpensive method for identifying and excluding non-genetic risk factors for colorectal cancer. Molecular Aspects of Medicine 2019; 69: 41 doi: 10.1016/j.mam.2019.01.002
|
| 74 |
Hyun Joo Jang. Can Statin Prevent the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Disease?. Gut and Liver 2019; 13(2): 138 doi: 10.5009/gnl19003
|
| 75 |
Ka Shing Cheung, Esther W. Chan, Wai Kay Seto, Ian C.K. Wong, Wai K. Leung. ACE (Angiotensin-Converting Enzyme) Inhibitors/Angiotensin Receptor Blockers Are Associated With Lower Colorectal Cancer Risk. Hypertension 2020; 76(3): 968 doi: 10.1161/HYPERTENSIONAHA.120.15317
|
| 76 |
Yakir Segev, Ofer Gemer, Limor Helpman, Nasreen Hag‐Yahia, Ram Eitan, Oded Raban, Zvi Vaknin, Alon Ben‐Arie, Amnon Amit, Tally Levy, Ahmed Namazov, Michael Voldarsky, Inbar Ben Shachar, Ilan Atlas, Ilan Bruchim, Ofer Lavie. An Israeli Gynecologic Oncology Group study of statin use and endometrial cancer prognosis. International Journal of Gynecology & Obstetrics 2020; 148(1): 79 doi: 10.1002/ijgo.12981
|
| 77 |
Sarah Ouahoud, Rutger J. Jacobs, Maikel P. Peppelenbosch, G. M. Fühler, Jarom Heijmans, Sander Diks, Manon E. Wildenberg, Lukas J. A. C. Hawinkels, Liudmila L. Kodach, Philip W. Voorneveld, James C. H. Hardwick. Kinome-wide analysis of the effect of statins in colorectal cancer. British Journal of Cancer 2021; 124(12): 1978 doi: 10.1038/s41416-021-01318-9
|
| 78 |
Ai-juan Li, Hai-yin Jiang, Yong-hui Jia. Statin exposure and risk of colorectal cancer in patients with inflammatory bowel disease: a systematic review and meta-analysis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1507739
|
| 79 |
D. Heresbach, P. Pienkowski. Risque moyen ou élevé de cancer colorectal : comment classer en 2014 ? Faut-il changer le paradigme ?. Acta Endoscopica 2014; 44(5): 268 doi: 10.1007/s10190-014-0411-z
|
| 80 |
Chris Wakeman, Jacqueline Keenan, Jimmy Eteuati, Paul Hollington, Tim Eglinton, Frank Frizelle. Chemoprevention of colorectal neoplasia. ANZ Journal of Surgery 2017; 87(12) doi: 10.1111/ans.13392
|
| 81 |
Tanja Tomić, Santiago Domínguez-López, Rocío Barrios-Rodríguez. Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: A systematic review and meta-analysis. Cancer Epidemiology 2019; 58: 52 doi: 10.1016/j.canep.2018.11.002
|
| 82 |
Ka-Shing Cheung, Lijia Chen, Esther W Chan, Wai-Kay Seto, Ian C K Wong, Wai K Leung. Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients. Gut 2019; 68(11): 1979 doi: 10.1136/gutjnl-2018-317714
|
| 83 |
Roger J. Bedimo, Lesley S. Park, Fatima M. Shebl, Keith Sigel, Christopher T. Rentsch, Kristina Crothers, Maria C. Rodriguez-Barradas, Matthew Bidwell Goetz, Adeel A. Butt, Sheldon T. Brown, Cynthia Gibert, Amy C. Justice, Janet P. Tate. Statin exposure and risk of cancer in people with and without HIV infection. AIDS 2021; 35(2): 325 doi: 10.1097/QAD.0000000000002748
|
| 84 |
Bettina Kulle Andreassen, Nathalie C Støer, Jan Ivar Martinsen, Giske Ursin, Elisabete Weiderpass, G Hege Thoresen, Karen Boldingh Debernard, Øystein Karlstad, Anton Pottegard, Søren Friis. Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study. BMJ Open 2019; 9(4): e028504 doi: 10.1136/bmjopen-2018-028504
|
| 85 |
Andy Göbel, Martina Rauner, Lorenz C. Hofbauer, Tilman D. Rachner. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(2): 188351 doi: 10.1016/j.bbcan.2020.188351
|
| 86 |
D. Heresbach, P. Bulois. Risque de néoplasie colorectale, comorbidités et facteurs environnementaux. Faut-il revoir les recommandations de dépistage en 2014 ?. Acta Endoscopica 2014; 44(5): 240 doi: 10.1007/s10190-014-0401-1
|
| 87 |
A. Gaisser. Onkologie und Versorgung in Fach- und Publikumsmedien. Der Onkologe 2018; 24(6): 495 doi: 10.1007/s00761-018-0383-2
|